Oxford BioMedica Plc - Company Profile
Powered by 
All the data and insights you need on Oxford BioMedica Plc in one report.
$295
- Save hours of research time and resources with
our up-to-date Oxford BioMedica Plc Strategy Report
- Understand Oxford BioMedica Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Oxford BioMedica Plc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP4058067A1 | Application | PRODUKTIONSSYSTEM | A61K48/00; C12N15/67; C12N15/86; C12N2740/16043; C12N2740/16051; C12N2750/14143; C12N2750/14151; C12N2840/102; C12N2840/20; C12N2840/203; C12N2840/55 | September 21, 2022 |
| US11427645B2 | Grant | 5T4-targeting agents and methods | A61K2039/505; A61K2039/54; A61K2039/545; A61K35/17; A61K38/1774; A61K39/39558; A61K45/06; A61K47/6857; A61K47/6867; A61K47/6869; A61K9/0019; A61P35/00; A61P35/02; C07K14/7051; C07K14/70517; C07K14/70578; C07K16/30; C07K2317/622; C07K2317/76; C07K2319/02; C07K2319/03; C07K2319/30; C07K2319/33; C12N2510/00; C12N5/0636 | August 30, 2022 |
| KR1020220097492A | Application | 생산 시스템 | A61K48/00; C12N15/67; C12N15/86; C12N2740/16043; C12N2740/16051; C12N2750/14143; C12N2750/14151; C12N2840/102; C12N2840/20; C12N2840/203; C12N2840/55 | July 07, 2022 |
| GB202207462D0 | Application | Gene therapy-based system for treating a metabolic disorder | July 06, 2022 | |
| CN114667161A | Application | 生产系统 | A61K48/00; C12N15/67; C12N15/86; C12N2740/16043; C12N2740/16051; C12N2750/14143; C12N2750/14151; C12N2840/102; C12N2840/203; C12N2840/55 | June 24, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer